Marksans Pharma share price
You have to be logged in to add this to Watchlist.Marksans Pharma is trading 2.32% upper at Rs 315.70 as compared to its last closing price. Marksans Pharma has been trading in the price range of 318.70 & 310.00. Marksans Pharma has given 91.59% in this year & 0.96% in the last 5 days.
Marksans Pharma has TTM P/E ratio 38.88 as compared to the sector P/E of 33.29.There are 2 analysts who have initiated coverage on Marksans Pharma. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 96.72 Crores in its last quarter.
Listed peers of Marksans Pharma include Jubilant Pharmova (-2.39%), Caplin Point Laboratories (0.23%), Marksans Pharma (2.32%) etc.
Marksans Pharma has a 56.13% public holding.The Mutual Fund holding in Marksans Pharma was at 3.02% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Marksans Pharma was at 10.43% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Marksans Pharma share price range
|
| ||||
|
| ||||
Marksans Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 13,986.90 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Marksans Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 12-Nov-24 | Quarterly Results |
| 13-Aug-24 | Quarterly Results |
| 30-May-24 | Audited Results & Final Dividend |
| 13-Feb-24 | Quarterly Results |
| 09-Nov-23 | Quarterly Results |
| 11-Aug-23 | Quarterly Results |
| 30-May-23 | Audited Results & Final Dividend |
| 13-Feb-23 | Quarterly Results |
| 20-Jan-23 | Others |
| 14-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 24-Sep-24 | 19-Aug-24 | AGM |
| 28-Aug-23 | 01-Aug-23 | AGM |
| 23-Sep-21 | 11-Aug-21 | AGM |
| 09-Jul-21 | 16-Jun-21 | EGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 30-May-24 | 17-Sep-24 | 17-Sep-24 | 0.6 |
| 25-May-23 | 07-Jun-23 | 07-Jun-23 | 0.5 |
| 31-May-21 | - | 15-Sep-21 | 0.25 |
FAQs about Marksans Pharma share price
Marksans Pharma is trading at 315.70 as on Mon Nov 25 2024 10:10:44. This is 2.32% upper as compared to its previous closing price of 308.55.
The market capitalization of Marksans Pharma is 13986.90 Cr as on Mon Nov 25 2024 10:10:44.
The average broker rating on Marksans Pharma is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Marksans Pharma is 328.35 whereas the 52 wk low is 126.05
Marksans Pharma can be analyzed on the following key metrics -
- TTM P/E: 38.88
- Sector P/E: 33.29
- Dividend Yield: 0.19%
- D/E ratio: 0.09
Marksans Pharma reported a net profit of 313.70 Cr in 2024.
Marksans Pharma Quick Links
Marksans Pharma Dividend Marksans Pharma Bonus Marksans Pharma News Marksans Pharma AGM Marksans Pharma Rights Marksans Pharma Splits Marksans Pharma Board Meetings Marksans Pharma Key Metrics Marksans Pharma Shareholdings Marksans Pharma Profit Loss Marksans Pharma Balance Sheet Marksans Pharma Cashflow Marksans Pharma Q1 Results Marksans Pharma Q2 Results Marksans Pharma Q3 Results Marksans Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks